- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Scottish Life Science Sector Receives Euro 26 Million Boost
11 December.
The announcement of a new 10,000 sq m bio-incubator for the Edinburgh BioQuarter confirms the latest £24 million (E26.4 million) investment in the Scottish life sciences cluster.
The facility will be jointly funded by the UK Department for Business Innovation and Skills through the Strategic Investment Fund and Scottish Enterprise. Welcoming the announcement, Lena Wilson, chief executive of Scottish Enterprise, said: "The BioQuarter is one of the largest projects of its type in Europe and this funding will allow the partners to cement Scotland's position as one of the most dynamic locations for life sciences globally."
The bio-incubator is targeted at start-up and spin-out biotechnology companies, and will help to create 200 jobs in Edinburgh over the next five years. It will offer access to high-cost specialized equipment, advice, mentoring and expertise to support successful product development.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
